logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 7618789 B1

PDFFull Text
Expired
Date of Patent:
Nov. 17, 2009

Filed:

Apr. 03, 2002

Use of semenogelin in the diagnosis, prognosis and treatment of cancer

Applicants:

David D. Roberts, Bethesda, MD (US);

Henry C. Krutzsch, Bethesda, MD (US);

Christine Krutzsch, Legal Representative, Bethesda, MD (US);

Inventors:

David D. Roberts, Bethesda, MD (US);

Henry C. Krutzsch, Bethesda, MD (US);

Christine Krutzsch, legal representative, Bethesda, MD (US);

Assignee:

The United States of America as represented by the Secretary of Department of Health and Human Services, Washington, DC (US);

Attorney:

Leydig, Voit & Mayer, Ltd.

Primary Examiner:

Brandon J Fetterolf

Int. Cl.
CPC ...
G01N 33/574 (2006.01);
U.S. Cl.
CPC ...
Abstract

Method of diagnosing cancer in a male mammal comprising obtaining and assaying a test sample for an increased level of semenogelin; method of diagnosing cancer in a female mammal comprising obtaining and assaying a test sample for the presence of semenogelin; methods of prognosticating and assessing the effectiveness of treatment of a cancer in a mammal comprising measuring the level of semenogelin in a test sample; method of inducing an immune response to a cancer in a mammal comprising administering to the mammal a composition comprising (a) an immune-response inducing effective amount of (i) semenogelin or (ii) antibody thereto or (b) a recombinant vector encoding and expressing an immune-response inducing effective amount of (i) or (ii); and composition comprising a carrier and (a) an immune-response inducing effective amount of (i) a polypeptide of any of SEQ ID NOS:1-27 or (ii) antibody thereto or (b) a recombinant vector encoding and expressing an immune-response inducing effective amount of (i) or (ii).

Find Patent Forward Citations

Roberts, David. (2009). Use of semenogelin in the diagnosis, prognosis and treatment of cancer (U.S. Patent No. 7618789). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/7618789

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…